53 The triple immunostain cocktail recommended for diagnosing limited prostatic
adenocarcinoma (2016 WHO, p.147) comprises
(A) AMACR/NKX3.1/high-molecular weight cytokeratin
(B)AMACR/p63/ high-molecular weight cytokeratin
(C)AE1/AE3/AMACR
(D)ERG/PSMA/NKX3.1
阿摩線上測驗
登入